Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
Christiana M. Neophytou, Panagiotis Boutsikos, Panagiotis Papageorgis
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 149

Showing 26-50 of 149 citing articles:

Adapalene and Doxorubicin Synergistically Promote Apoptosis of TNBC Cells by Hyperactivation of the ERK1/2 Pathway Through ROS Induction
Umar Mehraj, Irfan Ahmad Mir, Mahboob Ul Hussain, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 27
Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941
Umar Mehraj, Nissar Ahmad Wani, Abid Hamid, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Hybrid membrane-camouflaged hollow prussian blue nanoparticles for shikonin loading and combined chemo/photothermal therapy of metastatic TNBC
Jiahao Liang, Chao Wang, Jialong Fan, et al.
Materials Today Advances (2022) Vol. 14, pp. 100245-100245
Open Access | Times Cited: 24
3′-epi-12β-hydroxyfroside-mediated autophagy degradation of RIPK1/RIPK3 necrosomes leads to anergy of immunogenic cell death in triple-negative breast cancer cells
Feng‐Ying Huang, Shu-Zhen Dai, Wentian Xu, et al.
Pharmacological Research (2022) Vol. 187, pp. 106613-106613
Open Access | Times Cited: 23
Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis
Maria Kalli, Fotios Mpekris, Chen Khuan Wong, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 38
Long non‑coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4
Xiang Xiong, Yeqian Feng, Lun Li, et al.
Oncology Reports (2020)
Open Access | Times Cited: 36
[10]-Gingerol improves doxorubicin anticancer activity and decreases its side effects in triple negative breast cancer models
Ana Carolina Baptista Moreno Martin, Rebeka Tomasin, Liany Luna-Dulcey, et al.
Cellular Oncology (2020) Vol. 43, Iss. 5, pp. 915-929
Closed Access | Times Cited: 36
Organotypic breast tumor model elucidates dynamic remodeling of tumor microenvironment
Sunil Singh, Lucille A. Ray, Pradip Shahi Thakuri, et al.
Biomaterials (2020) Vol. 238, pp. 119853-119853
Open Access | Times Cited: 33
A synchronized dual drug delivery molecule targeting cancer stem cells in tumor heterogeneity and metastasis
Ji Hyeon Kim, Jung Min Park, Eunsun Jung, et al.
Biomaterials (2022) Vol. 289, pp. 121781-121781
Closed Access | Times Cited: 19
KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?
Sitaram Harihar, Danny R. Welch
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 1, pp. 183-196
Open Access | Times Cited: 11
Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer
Mandana Azari, Farbod Bahreini, Vladimir N. Uversky, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115459-115459
Closed Access | Times Cited: 11
Disarib, a Specific BCL2 Inhibitor, Induces Apoptosis in Triple-Negative Breast Cancer Cells and Impedes Tumour Progression in Xenografts by Altering Mitochondria-Associated Processes
Meghana Manjunath, Febina Ravindran, Shivangi Sharma, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6485-6485
Open Access | Times Cited: 4
Identification of the tumor metastasis-related tumor subgroups overexpressed NENF in triple-negative breast cancer by single-cell transcriptomics
Guixin Wang, Cangchang Shi, Long He, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Uncarboxylated osteocalcin induced miR-143-3p targets SP7 and activates PI3K/Akt signaling in TNBC cells to promote invasion and migration
Qian Du, Jiaojiao Xu, Miao Zhang, et al.
Translational Oncology (2025) Vol. 53, pp. 102305-102305
Open Access
Metastasizing to the colon from triple-negative breast cancer: A case report and review of literature
Benquan Wang, Xinyi Fang, Ben-Hong Xiang, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 3
Closed Access
miRNAs as emerging predictors of tamoxifen resistance in breast cancer
Elmira Aboutalebi Vand Beilankouhi, Reza Safaralizadeh, Babak Nejati, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
CircRNAs: a novel potential strategy to treat breast cancer
Pangzhou Chen, Jinhui Zhang, Song Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Current knowledge on the mechanisms underpinning vasculogenic mimicry in triple negative breast cancer and the emerging role of nitric oxide
Belete Kassa Alemu, Sara Tommasi, Julie-Ann Hulin, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118013-118013
Closed Access
Ultrasmall lactoferrin/lipid multicompartmental nanomedicine-based reprogramming of glycolysis in triple-negative breast cancer via HDAC6/LDH axis enhances cancer immunotherapy
Islam A. Hassanin, Hesham Saeed, Michael G. Shehat, et al.
Chemical Engineering Journal (2025), pp. 163015-163015
Closed Access
Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis
Xiao Yang, Xin‐hua Liang, Min Zheng, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 34
Synthesis and evaluation of chalcone analogues containing a 4-oxoquinazolin-2-yl group as potential anti-tumor agents
Xue Han, Bin Peng, Beibei Xiao, et al.
European Journal of Medicinal Chemistry (2018) Vol. 162, pp. 586-601
Closed Access | Times Cited: 34
Duality of iron (III) doped nano hydroxyapatite in triple negative breast cancer monitoring and as a drug-free therapeutic agent
Tiago P. Ribeiro, Fernando J. Monteiro, Marta S. Laranjeira
Ceramics International (2020) Vol. 46, Iss. 10, pp. 16590-16597
Closed Access | Times Cited: 32
HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation
Tahiyat Alothaim, Morgan Charbonneau, Xiaohu Tang
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27
Fighting secondary triple-negative breast cancer in cerebellum: A powerful aid from a medicinal mushrooms blend
Fabrizio De Luca, E. Roda, Daniela Ratto, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114262-114262
Open Access | Times Cited: 10
Lupeol synergizes with 5-fluorouracil to combat c-MET/EphA2 mediated chemoresistance in triple negative breast cancer
Debarpan Mitra, Depanwita Saha, Gaurav Das, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108395-108395
Open Access | Times Cited: 10

Scroll to top